Skip to main content
iwCLL 2025 Main banner
Final Program


Save The Date

    (1606) Epcoritamab Monotherapy in Patients with First-Line Richter’s Transformation: 2-Year Follow-Up Results From the Phase 1b/2 EPCORE CLL-1 Clinical Trial

    Sunday, September 14, 2025
    12:55 - 13:05 CEST
    Location: ICE, Auditorium Hall (S1), Entrances On Level 0 & 1
    Oral

      Primary Author / Presenter(s)

    • Arnon P. Kater, MD, PhD

      Vice Chair, Hematologist & Principal Scientist
      Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, and HOVON
      Amsterdam, Noord-Holland, Netherlands